The quick takeaway from last week’s Allergan action: Round 1 goes to David Pyott on points—and an acquisition would knock Valeant out cold … Would-be Allergan raider Bill Ackman had a rough time on two fronts last week—his bid to force the Irvine-based drug maker into Valeant’s fold lost ground, and an attempt to blacken the eye of Herbalife backfired...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99